Jazz Pharmaceuticals

Source: www.bignewsnetwork.com --- 5 days ago
Posted on: Monday, 6 October 2008, 18:00 CDT PALO ALTO, Calif., Oct. 6 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. announced today that Bruce C. Cozadd, the company's Executive Chairman, w... ...

Source: chronicfatigue.about.com --- 30 days ago
NEWSBRIEF: Another drug is expected to go befoe the FDA as a potential fibromyalgia treatment. Jazz Pharmaceuticals says it has wrapped up its first Phase III trial of the... ...

Source: www.prnewswire.com --- 83 days ago
...

Source: www.bignewsnetwork.com --- 87 days ago
Posted on: Wednesday, 16 July 2008, 09:01 CDT PALO ALTO, Calif., July 16 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. announced today that it has entered into definitive agreements with selec... ...

Source: www.smallcapinvestor.com --- 26 days ago
Federal Agricultural Mortgage Corp. (Nasdaq: AGM ), Targacept Inc. (Nasdaq: TRGT ) and North American Galvanizing & Coatings Inc. (Nasdaq: NGA ) are among the biggest percentage losers in Tuesday's trading among companies with market capitalizations under $1 billion. Also included among the results: Innovative Solutions and Support Inc. (Nasdaq: ISSC ), Jazz Pharmaceuticals Inc. (Nasdaq: Jazz ), Astronics Corp. (Nasdaq: ATRO ), Elbit Imaging Ltd. (Nasdaq: EMITF ), Targa Resources Partners L.P. (Nasdaq: NGLS ) and Quest Energy Partners L.P. (Nasdaq: QELP ). Here are the biggest percentage losers among small caps: ...

Source: www.fwicki.com --- 87 days ago
Jazz Pharmaceuticals, Inc. announced today that it has entered into definitive agreements with selected investors to sell 3,848,289 units , with each Unit consisting of one share of the Company's common stock, ... ...

Source: www.secfilings.com --- 53 days ago
Jazz Pharmaceuticals Inc Files SEC Form 4 - Statement of changes in beneficial ownership of securities ...

Source: www.biotechwatch.com --- 82 days ago
Jazz Pharmaceuticals completed the previously announced registered direct offering of 3,848,289 units, with each Unit consisting of (i) one share of the Company's common stock, par value $0.0001 per share, and (ii) a warrant to purchase 0.45 of a share of Common Stock, for gross proceeds of approximately $26.0 million, before deducting placement agents' fees and estimated offering expenses. Lazard Capital Markets LLC served as lead placement agent and Leerink Swann LLC served as co-placement agent for the offering ...